Last reviewed · How we verify
STP1
At a glance
| Generic name | STP1 |
|---|---|
| Sponsor | Stalicla SA |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Effects of Feel Free® Classic Tonic on Stress and Pharmacokinetics in Healthy Adults (NA)
- Effects of Dietary Supplements on Nail and Hair Health (NA)
- Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease (PHASE2)
- Evaluation of Sleep Quality in Head and Neck Cancer Patients Throughout Treatment Course
- To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria (PHASE3)
- Evaluation the Impact of the "Pas" Technique Versus the "Standard" Technique on Radiation Exposure (NA)
- A Pharmacokinetic Study of Single Oral Doses of Six Different Vitamin C Product Forms (NA)
- Safety, Tolerability and Pharmacokinetics Study of STP1 in a Subgroup of Patients With Autism Spectrum Disorder (ASD) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- STP1 CI brief — competitive landscape report
- STP1 updates RSS · CI watch RSS
- Stalicla SA portfolio CI